about
BF066, a novel dual target antiplatelet agent without significant bleedingbeta4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localizationMatrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivationOverexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient PrognosisCAPS1 Negatively Regulates Hepatocellular Carcinoma Development through Alteration of Exocytosis-Associated Tumor Microenvironment.Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway.Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells.Cdc34-mediated degradation of ATF5 is blocked by cisplatin.E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription.Simultaneous determination of blood glucose and isoleucine levels in rats after chronic alcohol exposure by microwave-assisted derivatization and isotope dilution gas chromatography/mass spectrometry.BIRC6 promotes hepatocellular carcinogenesis: interaction of BIRC6 with p53 facilitating p53 degradation.Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitisCell surface beta 1, 4-galactosyltransferase 1 promotes apoptosis by inhibiting epidermal growth factor receptor pathwaySynthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agentsMethotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patientsToll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways
P50
Q27334889-CEAE182D-A189-4E59-98D0-5B122BBD22BEQ28300014-A0153EC8-4B55-4F60-A8A9-6B385B31A162Q34442297-4609868E-3D33-4071-9633-9657D4F61F65Q35561267-B40F2B59-7508-4404-AD05-7FCE06101083Q36743574-D66C8D1B-B4F3-4301-B9FE-224D88F55440Q37377240-F0EEA322-FA5A-4045-B3D8-20374C692C55Q38784125-7776492B-2DD4-4305-9922-004609368CD6Q39928037-D1D2AC4A-2AE8-40CB-ADCD-F283F9593104Q39985191-0920B6D9-6B60-4CBA-BAFD-1A8B2D1C5CCEQ40139506-88F3FB13-B85D-498D-9148-C16F03345867Q46846409-CC922475-99D9-402A-81B8-6ADED656DD5BQ53022205-047CB0FC-DAFA-4B84-8D2A-2BEA5C339E63Q57111615-1981F6C8-C247-4E12-85BE-A8D47E3CB3C9Q57152457-9FCF376C-A285-4A2B-97F2-96F18C57D529Q79756285-97DFADBB-E9A1-4F62-B9C0-F974C94883DEQ83983937-7BC49FA1-5497-4A4C-97F4-D90056D415F7Q84404990-EB82BD74-D7B4-4711-B166-F7061359E4DFQ87849131-A33FE929-E990-484E-9D4F-64B72AAA2A41
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Si Zhang
@ast
Si Zhang
@en
Si Zhang
@es
Si Zhang
@nl
type
label
Si Zhang
@ast
Si Zhang
@en
Si Zhang
@es
Si Zhang
@nl
prefLabel
Si Zhang
@ast
Si Zhang
@en
Si Zhang
@es
Si Zhang
@nl
P106
P1153
55713597300
P31
P496
0000-0002-5682-4995